CBD accelerates gut healing after radiation damage in mice

Cannabidiol triggers fatty acids β-oxidation mediated by Stat2 to facilitate intestinal stem cells regeneration post radiation.

Experimental & molecular medicine • • Moderately Relevant
🤖

AI Summary

Researchers have discovered that cannabidiol (CBD) can dramatically accelerate the recovery of intestinal cells damaged by radiation exposure. In animal studies, mice exposed to lethal radiation doses that received CBD showed significantly improved body weight retention and enhanced proliferation of intestinal stem cells—the fundamental building blocks needed to repair the gut lining. This finding is particularly relevant because radiation therapy, while essential for cancer treatment, often causes severe gastrointestinal damage that limits patients' quality of life.

The study reveals a sophisticated molecular mechanism behind CBD's protective effects. CBD activates a cellular energy program called fatty acid β-oxidation (FAO), which intestinal stem cells depend on for regeneration after radiation injury. The research identified a specific pathway: CBD binds to a protein called THOC3, stabilizing it and allowing a regulatory protein called Stat2 to move into the cell nucleus. Once there, Stat2 activates PPARα, a master regulator that switches on the genes responsible for fatty acid metabolism. This metabolic shift appears to be essential for stem cells to recover and repopulate the damaged intestinal tissue.

These findings open a promising avenue for protecting cancer patients undergoing radiation therapy. Unlike traditional supportive care approaches, CBD targets the fundamental biological process needed for intestinal recovery, rather than simply masking symptoms. The research suggests that CBD could complement radiation treatment by preventing the gastrointestinal syndrome that often forces doctors to reduce or pause therapy. While human clinical trials are still needed to confirm these laboratory findings, this work demonstrates how cannabis-derived compounds can address serious medical complications through precise molecular mechanisms rather than through broad immunosuppression.

📄 Original Abstract

The development of compounds triggering intestinal stem cells (ISCs) proliferation represents a promising strategy to alleviate irradiation (IR)-induced gastrointestinal syndrome. Here, cannabidiol (CBD)-a nonpsychotomimetic phytocannabinoid derived from the Cannabis sativa plant-was found to dramatically improve body weight loss of mice and stimulate Lgr5+ ISCs proliferation upon a lethal dose of IR. Using absolute quantitative lipidomics, we found that the dysregulation of fatty acids in crypts induced by IR was rescued by CBD, which was indispensable for ISCs regeneration. Integrative analysis of transcriptome and lipidomics unveiled the critical role of PPARα in regulating fatty acid β-oxidation (FAO) by transcriptionally upregulating Slc27a2 and Acox1. Further experiments showed that CBD could trigger the enrichment of Stat2 on the promoter region of Pparα, ultimately facilitating the FAO program and subsequent ISCs proliferation following IR exposure. In addition,THOC3 was identified as a direct target of CBD, which stabilized the THOC3 protein and substantially alleviated the IR-induced blockade of Stat2 mRNA nuclear export. This study reveals a connection between CBD-driven ISCs proliferation and the FAO program during IR damage, providing a promising avenue for IR-induced gastrointestinal syndrome treatment. The binding of CBD to THOC3 maintains its radiation stability, which then supports the nuclear export of Stat2 mRNA for the subsequent transactivation of Pparα. The upregulation of PPARα will ultimately stimulate the FAO program, thereby facilitating ISCs regeneration during IR exposure.

Explore More Research

Stay informed about the latest cannabis science.

Your stash, decoded.